MA39549B1 - Comprimé dispersible de misoprostol - Google Patents
Comprimé dispersible de misoprostolInfo
- Publication number
- MA39549B1 MA39549B1 MA39549A MA39549A MA39549B1 MA 39549 B1 MA39549 B1 MA 39549B1 MA 39549 A MA39549 A MA 39549A MA 39549 A MA39549 A MA 39549A MA 39549 B1 MA39549 B1 MA 39549B1
- Authority
- MA
- Morocco
- Prior art keywords
- misoprostol
- dispersible
- tablet
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une formulation pharmaceutique solide comportant du misoprostol ou son sel pharmaceutiquement acceptable. En particulier, l'invention concerne un comprimé dispersible comprenant du misoprostol ou son sel pharmaceutiquement acceptable, procurant d'autres voies d'administration. Ledit comprimé est particulièrement adapté à la maturation du col de l'utérus, l'induction du travail, la prévention et/ou le traitement de l'hémorragie post-avortement ou post-partum.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14176821.8A EP2965750B1 (fr) | 2014-07-11 | 2014-07-11 | Comprimé dispersible de misoprostol |
PCT/DK2015/050216 WO2016004960A2 (fr) | 2014-07-11 | 2015-07-10 | Comprimé dispersible de misoprostol |
Publications (2)
Publication Number | Publication Date |
---|---|
MA39549A1 MA39549A1 (fr) | 2017-12-29 |
MA39549B1 true MA39549B1 (fr) | 2019-04-30 |
Family
ID=51167770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39549A MA39549B1 (fr) | 2014-07-11 | 2015-07-10 | Comprimé dispersible de misoprostol |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP3238715A1 (fr) |
CY (1) | CY1119193T1 (fr) |
DK (1) | DK2965750T3 (fr) |
ES (1) | ES2645481T3 (fr) |
HR (1) | HRP20171220T1 (fr) |
HU (1) | HUE033619T2 (fr) |
LT (1) | LT2965750T (fr) |
MA (1) | MA39549B1 (fr) |
PL (1) | PL2965750T3 (fr) |
PT (1) | PT2965750T (fr) |
RS (1) | RS56468B1 (fr) |
SI (1) | SI2965750T1 (fr) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006125450A1 (fr) | 2005-05-26 | 2006-11-30 | Atef Mohammed Mostafa Darwish | Suppositoires rectaux et vaginaux contenant du misoprostol |
WO2006133048A2 (fr) | 2005-06-03 | 2006-12-14 | Duramed Pharmaceuticals, Inc. | Compositions pharmaceutiques comprenant des agonistes des recepteurs prostanoides et procedes de fabrication et d'utilisation de celles-ci |
US7799530B2 (en) | 2005-09-23 | 2010-09-21 | Celera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
WO2007035954A2 (fr) | 2005-09-23 | 2007-03-29 | Duramed Pharmaceuticals, Inc. | Comprimes vaginaux comportant du misoprostol et leurs procedes de fabrication et d'utilisation |
WO2009154810A2 (fr) * | 2008-02-25 | 2009-12-23 | Dr. Reddy's Laboratories Ltd. | Systèmes d'administration de multiples principes actifs |
CN102697746B (zh) * | 2012-06-11 | 2014-03-19 | 广州朗圣药业有限公司 | 一种快速融变的米索前列醇阴道用组合物及其制备方法和应用 |
MX2015001007A (es) | 2012-07-26 | 2015-04-09 | Ferring Bv | Composicion de misoprostol. |
CN102872024B (zh) * | 2012-09-28 | 2015-06-17 | 天津市聚星康华医药科技有限公司 | 口腔内使用的米索前列醇药物组合物 |
CN103340837B (zh) * | 2013-07-08 | 2018-04-27 | 天津市聚星康华医药科技有限公司 | 一种米索前列醇阴道泡腾片及其制备方法 |
-
2014
- 2014-07-11 LT LTEP14176821.8T patent/LT2965750T/lt unknown
- 2014-07-11 PT PT141768218T patent/PT2965750T/pt unknown
- 2014-07-11 SI SI201430402T patent/SI2965750T1/sl unknown
- 2014-07-11 ES ES14176821.8T patent/ES2645481T3/es active Active
- 2014-07-11 PL PL14176821T patent/PL2965750T3/pl unknown
- 2014-07-11 RS RS20170828A patent/RS56468B1/sr unknown
- 2014-07-11 DK DK14176821.8T patent/DK2965750T3/en active
- 2014-07-11 EP EP17176202.4A patent/EP3238715A1/fr not_active Withdrawn
- 2014-07-11 HU HUE14176821A patent/HUE033619T2/en unknown
- 2014-07-11 EP EP14176821.8A patent/EP2965750B1/fr active Active
-
2015
- 2015-07-10 MA MA39549A patent/MA39549B1/fr unknown
-
2017
- 2017-08-08 CY CY20171100848T patent/CY1119193T1/el unknown
- 2017-08-09 HR HRP20171220TT patent/HRP20171220T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
DK2965750T3 (en) | 2017-10-16 |
EP2965750B1 (fr) | 2017-08-02 |
LT2965750T (lt) | 2017-09-25 |
HRP20171220T1 (hr) | 2017-11-03 |
SI2965750T1 (sl) | 2017-11-30 |
PT2965750T (pt) | 2017-10-03 |
EP2965750A1 (fr) | 2016-01-13 |
EP3238715A1 (fr) | 2017-11-01 |
MA39549A1 (fr) | 2017-12-29 |
HUE033619T2 (en) | 2017-12-28 |
CY1119193T1 (el) | 2018-02-14 |
ES2645481T3 (es) | 2017-12-05 |
PL2965750T3 (pl) | 2018-01-31 |
RS56468B1 (sr) | 2018-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA41060A (fr) | Compositions comprenant des souches bactériennes | |
MA55434A (fr) | Compositions comprenant des souches bactériennes | |
MA40755B1 (fr) | Compositions comprenant des souches bactériennes | |
MA40754B1 (fr) | Compositions comprenant des souches bactériennes | |
MA41013A (fr) | Compositions comprenant des souches bactériennes | |
MA41010A (fr) | Compositions comprenant des souches bactériennes | |
EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
MX2015003229A (es) | Composiciones que comprenden mezclas de alcanos semifluorados. | |
MA39725B1 (fr) | Compositions pharmaceutiques de composés thérapeutiquement actifs | |
MA38253A1 (fr) | Compositions comprenant de la vortioxétine et du donépézil | |
MA43876A (fr) | Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale | |
MX2020012800A (es) | Cannabinoides y usos de los mismos. | |
EA202190510A1 (ru) | Новое лекарственное средство для лечения воспалительной болезни кишечника | |
MA39447A1 (fr) | (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
WO2019004788A3 (fr) | Composition pharmaceutique comprenant de la broussochalcone a à titre de principe actif pour la prévention ou le traitement d'une maladie inflammatoire de l'intestin | |
MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
MA39549B1 (fr) | Comprimé dispersible de misoprostol | |
PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
BR112017019364A2 (pt) | dispersões sólidas | |
EA201791686A1 (ru) | Клизма для ректального введения | |
MX2017000399A (es) | Tableta dispersable de misoprostol. | |
MX2018003564A (es) | 1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cancer. | |
JO3321B1 (ar) | قرص قابل للتشتت من ميزوبروستول | |
MA41104A (fr) | Compositions comprenant des souches bactériennes | |
MA41059A (fr) | Compositions comprenant des souches bactériennes |